The global Enzyme-Linked Immunoassay (EIA) Market is forecasted to reach USD 26.40 Billion by 2027, according to a new report by Reports and Data. Immunoassay analyzer has a key benefit of monitoring transfusion medicine as in blood transfusion and organ transplant, which is likely to increase its demand. Few clinical immunoanalyzer employ automated analyzer to reduce manual intervention and chances of error as well as improve the workflow.

The increasing adoption of the immunoassay analyzer will boost the growth of the market. There is a rising prevalence of chronic and infectious diseases around the globe, requesting the need for early diagnosis. The growing demand for diagnostics is expected to be the key driving factor of the immunoassay analyzer market. Development in the sectors of genomics and proteomics has made the database of biomarkers expand by each day. The discovery and growing research on biomarkers of various diseases have led researchers and experts to use this knowledge to create new assays for diagnostics. Rising investments in R&D to develop new tests for the diagnosis of the diseases will promote the growth of the industry during the forecast period.

Request a sample Report of Enzyme-Linked Immunoassay (EIA) Market @ https://www.reportsanddata.com/download-free-sample/3467

Further key findings from the report suggest

  • The Enzyme-Linked Immunoassay (EIA) is used to commonly measure antigens, antibodies, glycoproteins, and proteins in biological samples. For instance, HIV infection diagnosis, measurement of cytokines, and pregnancy tests. The segment is forecasted to grow with a CAGR of 5.2% during the forecast period.
  • Cancer/tumor profiling deploys a tumor-specific patient-focused approach for the treatment of cancer by precisely targeting the tumor of an individual patent. Predominantly, tumor profiling may be helpful in increasing the chances of a patient getting benefitted from prescribed therapies for disease treatment.
  • The market in the Asia Pacific region is expected to grow at the fastest rate of 5.9% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3467

Key Players covered in this report are

bioMerieux. Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Diagnostics, Beckman Coulter, Inc., Diasorin S.p.A., Siemens Healthcare GmbH, Sigma Aldrich. Co. LLC., and Boditech Med, Inc, among others.

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Immunofluorescence analyzers
  • Enzyme-Linked Immunoassay (EIA)
  • Chemiluminescence Immunoassay
  • Radioimmunoassay
  • Consumables & Accessories

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Oncology
  • Therapeutic Drug Monitoring
  • Endocrinology
  • Cardiology
  • Infectious Disease Testing
  • Autoimmune Disease
  • Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Enzyme-Linked Immunoassay (EIA) industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Enzyme-Linked Immunoassay (EIA) manufacturers and provides valuable insight into the market for companies and individuals.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Ask For customization of Report @ https://www.reportsanddata.com/request-customization-form/3467

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore More Industry Research by Reports and Data:

Breast Imaging Market @ https://www.biospace.com/article/breast-imaging-market-demand-2022-2028-rapid-integration-of-ai-in-breast-imaging-to-improve-screening-and-detection/

Defibrillator Market @ https://www.biospace.com/article/defibrillator-market-size-2022-2028-increase-in-implementation-of-technologically-advanced-defibrillators-upward-demand-for-superiority-medical-care-and-cardiovascular/

Transdermal Skin Patch Market @ https://www.biospace.com/article/transdermal-skin-patch-market-growth-2022-2028-increasing-benefits-of-transdermal-medicine-over-oral-and-swallowing-drugs-that-cause-nausea-and-vomiting/

PET-CT Scan Market @ https://www.biospace.com/article/pet-ct-scan-market-growth-2022-2028-rising-demand-for-better-diagnostic-technologies-increasing-use-of-pet-ct-solutions-for-cancer/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com